Dordaviprone is being evaluated in the Phase 3 ACTION trial that is currently enrolling H3 K27M-mutant diffuse glioma patients at over 145 sites in 15 countries. Chimerix expects interim OS data in ...

Minecon 2018 announced, we're going to Disney and more on MNU 14👕 LOGDOTZIP SHIRTS & MORE ► <a href=" SUBSCRIBE ► <a href=" 🔔 AND CLICK THE BELL!▬▬▬▬▬▬▬▬▬▬▬▬▬📰 Facebook ► <a href=" Twitter ► <a ...